The narrow therapeutic window of glycated hemoglobin and assay variability
- 1 December 1999
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 48 (12) , 1498-1502
- https://doi.org/10.1016/s0026-0495(99)90236-6
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications TrialDiabetes, 1996
- Comparisons of Studies on Diabetic Complications Hampered by Differences in GHb MeasurementsDiabetes Care, 1996
- Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year studyDiabetes Research and Clinical Practice, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Attitudes and Behaviors of Primary Care Physicians Regarding Tight Control of Blood Glucose in IDDM PatientsDiabetes Care, 1993
- Clinical Trial of Programmable Implantable Insulin Pump For Type I DiabetesDiabetes Care, 1992
- The Clinical Information Value of the Glycosylated Hemoglobin AssayNew England Journal of Medicine, 1984
- Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins.Journal of Clinical Investigation, 1983
- Mapping of Several Abnormal Hemoglobins by Horizontal Polyacrylamide Gel Isoelectric FocusingAmerican Journal of Clinical Pathology, 1976